A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

September 30, 2027

Conditions
Parkinson Disease
Interventions
DRUG

BHV-8000

BHV-8000 10 mg. Participants will take blinded investigational product (IP) once daily

DRUG

BHV-8000

BHV-8000 20 mg. Participants will take blinded investigational product (IP) once daily

DRUG

Placebo

Matching placebo taken once daily

Trial Locations (65)

10021

RECRUITING

Site-005, New York

10032

NOT_YET_RECRUITING

Site-072, New York

11725

NOT_YET_RECRUITING

Site-061, Commack

12208

NOT_YET_RECRUITING

Site-006, Albany

14609

NOT_YET_RECRUITING

Site-066, Rochester

19107

NOT_YET_RECRUITING

Site-022, Philadelphia

21287

NOT_YET_RECRUITING

Site-077, Baltimore

22903

NOT_YET_RECRUITING

Site-060, Charlottesville

23233

NOT_YET_RECRUITING

Site-009, Henrico

23601

NOT_YET_RECRUITING

Site-074, Newport News

29425

NOT_YET_RECRUITING

Site-076, Charleston

32209

NOT_YET_RECRUITING

Site-087, Jacksonville

32608

NOT_YET_RECRUITING

Site-085, Gainesville

32751

RECRUITING

Site-051, Maitland

33133

NOT_YET_RECRUITING

Site-050, Miami

33136

NOT_YET_RECRUITING

Site-081, Miami

33331

NOT_YET_RECRUITING

Site-099, Weston

33462

RECRUITING

Site-038, Atlantis

33486

RECRUITING

Site-017, Boca Raton

33613

NOT_YET_RECRUITING

Site-078, Tampa

35294

NOT_YET_RECRUITING

Site-049, Birmingham

38157

NOT_YET_RECRUITING

Site-046, Memphis

44195

NOT_YET_RECRUITING

Site-082, Cleveland

44718

NOT_YET_RECRUITING

Site-023, Canton

48109

NOT_YET_RECRUITING

Site-056, Ann Arbor

48334

RECRUITING

Site-015, Farmington Hills

53226

NOT_YET_RECRUITING

Site-052, Milwaukee

55130

NOT_YET_RECRUITING

Site-092, Saint Paul

55427

NOT_YET_RECRUITING

Site-088, Golden Valley

55455

NOT_YET_RECRUITING

Site-101, Minneapolis

63005

RECRUITING

Site-044, Chesterfield

66160

NOT_YET_RECRUITING

Site-029, Kansas City

72205

NOT_YET_RECRUITING

Site-010, Little Rock

74136

NOT_YET_RECRUITING

Site-053, Tulsa

77030

NOT_YET_RECRUITING

Site-083, Houston

78229

NOT_YET_RECRUITING

Site-054, San Antonio

78681

RECRUITING

Site-043, Round Rock

80045

NOT_YET_RECRUITING

Site-025, Aurora

80113

NOT_YET_RECRUITING

Site-040, Englewood

84108

NOT_YET_RECRUITING

Site-089, Salt Lake City

85258

NOT_YET_RECRUITING

Site-024, Scottsdale

85351

NOT_YET_RECRUITING

Site-079, Sun City

87106

NOT_YET_RECRUITING

Site-090, Albuquerque

89106

NOT_YET_RECRUITING

Site-097, Las Vegas

90033

NOT_YET_RECRUITING

Site-041, Los Angeles

90095

NOT_YET_RECRUITING

Site-093, Los Angeles

91786

NOT_YET_RECRUITING

Site-030, Upland

92037

NOT_YET_RECRUITING

Site-080, La Jolla

92868

NOT_YET_RECRUITING

Site-100, Orange

94304

NOT_YET_RECRUITING

Site-070, Palo Alto

97210

NOT_YET_RECRUITING

Site-091, Portland

98007

RECRUITING

Site-007, Bellevue

98122

NOT_YET_RECRUITING

Site-019, Seattle

99202

NOT_YET_RECRUITING

Site-102, Spokane

06030

NOT_YET_RECRUITING

Site-031, Farmington

06510

RECRUITING

Site-028, New Haven

06473

NOT_YET_RECRUITING

Site-084, North Haven

06905

NOT_YET_RECRUITING

Site-069, Stamford

02114

RECRUITING

Site-071, Boston

01805

NOT_YET_RECRUITING

Site-086, Burlington

02035

NOT_YET_RECRUITING

Site-004, Foxborough

03756

NOT_YET_RECRUITING

Site-094, Lebanon

07764

NOT_YET_RECRUITING

Site-048, Long Branch

08901

NOT_YET_RECRUITING

Site-075, New Brunswick

05401

NOT_YET_RECRUITING

Site-095, Burlington

Sponsors
All Listed Sponsors
lead

Biohaven Therapeutics Ltd.

INDUSTRY

NCT06976268 - A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease | Biotech Hunter | Biotech Hunter